buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated by Pfizer's Prevnar franchise. GSK said it is paying $2.1 billion upfront for ...

Zostavax and Shingrix are linked to protection for older adults in multiple studies.

In the US, this vaccine has received regulatory approval for active immunisation to prevent IMD caused by Neisseria meningitidis serogroups A, C, Y, and W in individuals from 2 months through 55 years ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

GSK plc announced that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of RSV vaccines including GSK’s Arexvy (Respiratory Syncytial Virus Vaccine, ...

and about one-fifth are positive for HSV-2. These two factors contribute to the risk for sexual transmission and therefore to the risk of late-pregnancy acquisition of HSV. Most neonatal herpes ...

PROVIDENCE, R.I. — When the nation's top health official, Robert F. Kennedy Jr., endorsed the measles vaccine this month, his comments made waves because he spent 20 years making false claims ...

The first vaccine to protect against the herpes ... There are five types of herpes virus, but herpes simplex-1 or HSV-1 and herpes simplex-2, HSV-2, are the most common. The first causes cold ...

[29,30–34] The exact role of these cells in the decidua remains to be established, but they have been shown to promote a type 2 dominant state ... especially with vaccines that have a strong ...

Uniphar is one of several pharmaceutical companies at Citywest business park. Picture: Post Reporter ...